E-LIB Suche - Ergebnisse für: Borzenkova, E.

1

P1080: COMPARISON OF NIVOLUMAB 40 MG EFFICACY VERSUS 3 MG/K..:

Fedorova, L. ; Lepik, K. ; Mikhailova, N....
HemaSphere. 6 (2022) - p. 970-971 , 2022

Link: https://doi.org/10.1097/..

2

RESPONSE TO NIVOLUMAB AS ≥3rd LINE THERAPY IN PTS WITH RELA..:

Lepik, K. ; Mikhaylova, N. ; Kondakova, E....
Hematological Oncology. 37 (2019) S2 - p. 495-495 , 2019

Link: https://doi.org/10.1002/..

3

RETREATMENT WITH NIVOLUMAB IN PATIENTS WITH R/R CLASSICAL H..:

Fedorova, L. ; Lepik, K. ; Mikhailova, N....
Hematological Oncology. 37 (2019) S2 - p. 496-497 , 2019

Link: https://doi.org/10.1002/..

4

TREATMENT OF RELAPSED AND REFRACTORY T‐CELL LYMPHOMAS: FIRS..:

Lepik, E. ; Kozlov, A. ; Borzenkova, E....
Hematological Oncology. 37 (2019) S2 - p. 473-474 , 2019

Link: https://doi.org/10.1002/..

5

Long-term outcomes of ruxolitinib therapy in steroid-refrac..:

Moiseev, I. S. ; Morozova, E. V. ; Bykova, T. A....
Bone Marrow Transplantation. 55 (2020) 7 - p. 1379-1387 , 2020

Link: https://doi.org/10.1038/..

6

COMBINATION OF NIVOLUMAB AND BENDAMUSTINE IN PATIENTS WITH ..:

Mikhailova, N.B. ; Lepik, K.V. ; Kondakova, E.V....
Hematological Oncology. 37 (2019) S2 - p. 494-495 , 2019

Link: https://doi.org/10.1002/..

7

P1080: COMPARISON OF NIVOLUMAB 40 MG EFFICACY VERSUS 3 MG/K..:

Fedorova, L ; Lepik, K ; Mikhailova, N...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430497/. , 2022

Link: http://www.ncbi.nlm.nih...

8

Динамика показателей по заболеваемости гонококковой инфекци..:

Mamina, Y. R ; Kokhanova, D. A ; Borzenkova, E. A...
Актуальные вопросы современной медицинской науки и здравоохранения: сборник статей IV Международной научно-практической конференции молодых учёных и студентов,.... , 2019

Link: http://elib.usma.ru/hand..

9

P1080: COMPARISON OF NIVOLUMAB 40 MG EFFICACY VERSUS 3 MG/K..:

L. Fedorova ; K. Lepik ; N. Mikhailova...
http://journals.lww.com/10.1097/01.HS9.0000847188.87255.f7. , 2022

Link: https://doi.org/10.1097/..

10

Current status of the epidemiology and outcome of lymphomas..:

M. . Popova ; E. . Zinina ; N. . Popova...
https://openrepository.ru/article?id=387361. , 2016

Link: https://openrepository.r..

11

Current status of the epidemiology and outcome of lymphomas..:

M. Popova ; E. Zinina ; N. Popova...
https://hiv.bmoc-spb.ru/jour/article/view/181/182. , 2016

Link: https://hiv.bmoc-spb.ru/..

12

Combined immunochemotherapy in patients with refractory/rel..:

A. A. Mamedova ; N. E. Mochkin ; V. O. Sarzhevskiy...
https://oncohematology.abvpress.ru/ongm/article/view/557. , 2022

Link: https://doi.org/10.17650..

13

Efficacy and safety of nivolumab in the treatment of relaps..:

K. V. Lepik ; N. V. Mikhailova ; E. V. Kondakova...
https://oncohematology.abvpress.ru/ongm/article/view/315. , 2019

Link: https://doi.org/10.17650..

14

1,2,3-Thiadiazolyl Isocyanates in the Synthesis of Biologic..:

Kalinina, T. A. ; Shakhmina, Yu. S. ; Glukhareva, T. V....
Chemistry of Heterocyclic Compounds. 50 (2014) 7 - p. 1039-1046 , 2014

Link: https://doi.org/10.1007/..

15

Mobilization of hematopoietic stem cells (HSCs) by using Pl..:

N B Mikhailova ; A L Alianskij ; E V Kondakova...
https://modernonco.orscience.ru/1815-1434/article/view/26941. , 2014

Link: https://doaj.org/article..